About US
Contact us
>>Back
Think the pharma M&A party will start winding down? Think again
- Publisher：
- Publication：2015/4/22
nvestors like pharma M&A. Drugmakers have money--or access to it. Ergo, look for the dealmaking frenzy to continue, a Morgan Stanley equity strategist says. The pharma industry accounted for 45% of U.S. M&A so far this quarter, Bloombergreports, and at least 20% of the value of all offers over the last two quarters. Report